Investigation of diabetes-induced changes to the lung microbiome

  • Research type

    Research Study

  • Full title

    Comparison of two approaches, using next-generation sequencing, to identify if the lung microbiome is altered in people with lung disease and diabetes compared to those without diabetes

  • IRAS ID

    256124

  • Contact name

    Stanislavs Vasiljevs

  • Contact email

    m1300134@sgul.ac.uk

  • Sponsor organisation

    St Georges University London

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Contrary to the popular belief that the lungs are sterile, it was recently discovered that the lung is inhabited by resident bacteria and that it possesses its own unique microbiome (microbiome - all bacteria and their genes at a specific location). Several chronic lung conditions, such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), have been shown to induce changes to the resident lung microbiome.

    High blood glucose (hyperglycaemia) has been linked to increased glucose concentration in the airway surface liquid (ASL). This has been shown to be associated with an increased risk of developing pulmonary infections in patients in the intensive care unit and in patients who have diabetes and chronic lung diseases.

    Next-generation sequencing utilising amplification of the 16S ribosomal RNA gene has become the standard for identifying bacterial species in the microbiota. 16S gene is present in all bacteria and allows precise species identification from a small amount of starting material, making it a strong choice for analysis of the samples with low bacterial yield, such as samples of lung microbiome.

    Currently, sampling the lung microbiome requires invasive methods such as lung biopsy, bronchoalveolar lavage or induced sputum. It is possible to collect samples of lung microbiome non-invasively using non-induced sputum, however, that requires the patient to be a sputum producer.

    This studies goal is to develop a non-invasive approach of sampling lung microbiome that would be applicable to every person.

  • REC name

    North East - Newcastle & North Tyneside 1 Research Ethics Committee

  • REC reference

    19/NE/0122

  • Date of REC Opinion

    21 May 2019

  • REC opinion

    Further Information Favourable Opinion